The global market for Human iPSCs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

iPSC are derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes.

North American market for Human iPSCs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Human iPSCs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Human iPSCs in Academic Research is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Human iPSCs include Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Human iPSCs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human iPSCs.

The Human iPSCs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human iPSCs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human iPSCs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Human iPSCs Market Report

Report Metric	Details
Report Name	Human iPSCs Market
Segment by Type	Skin Blood Cells
Segment by Application	Academic Research Drug Development and Discovery Toxicity Screening Regenerative Medicine Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human iPSCs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Human iPSCs Market report?

Ans: The main players in the Human iPSCs Market are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL

What are the Application segmentation covered in the Human iPSCs Market report?

Ans: The Applications covered in the Human iPSCs Market report are Academic Research, Drug Development and Discovery, Toxicity Screening, Regenerative Medicine, Others

What are the Type segmentation covered in the Human iPSCs Market report?

Ans: The Types covered in the Human iPSCs Market report are Skin, Blood Cells

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human iPSCs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Skin

1.2.3 Blood Cells

1.3 Market by Application

1.3.1 Global Human iPSCs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Academic Research

1.3.3 Drug Development and Discovery

1.3.4 Toxicity Screening

1.3.5 Regenerative Medicine

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Human iPSCs Market Perspective (2020-2031)

2.2 Global Human iPSCs Growth Trends by Region

2.2.1 Global Human iPSCs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Human iPSCs Historic Market Size by Region (2020-2025)

2.2.3 Human iPSCs Forecasted Market Size by Region (2026-2031)

2.3 Human iPSCs Market Dynamics

2.3.1 Human iPSCs Industry Trends

2.3.2 Human iPSCs Market Drivers

2.3.3 Human iPSCs Market Challenges

2.3.4 Human iPSCs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Human iPSCs Players by Revenue

3.1.1 Global Top Human iPSCs Players by Revenue (2020-2025)

3.1.2 Global Human iPSCs Revenue Market Share by Players (2020-2025)

3.2 Global Human iPSCs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Human iPSCs Revenue

3.4 Global Human iPSCs Market Concentration Ratio

3.4.1 Global Human iPSCs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human iPSCs Revenue in 2024

3.5 Global Key Players of Human iPSCs Head office and Area Served

3.6 Global Key Players of Human iPSCs, Product and Application

3.7 Global Key Players of Human iPSCs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Human iPSCs Breakdown Data by Type

4.1 Global Human iPSCs Historic Market Size by Type (2020-2025)

4.2 Global Human iPSCs Forecasted Market Size by Type (2026-2031)

5 Human iPSCs Breakdown Data by Application

5.1 Global Human iPSCs Historic Market Size by Application (2020-2025)

5.2 Global Human iPSCs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Human iPSCs Market Size (2020-2031)

6.2 North America Human iPSCs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Human iPSCs Market Size by Country (2020-2025)

6.4 North America Human iPSCs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Human iPSCs Market Size (2020-2031)

7.2 Europe Human iPSCs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Human iPSCs Market Size by Country (2020-2025)

7.4 Europe Human iPSCs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Human iPSCs Market Size (2020-2031)

8.2 Asia-Pacific Human iPSCs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Human iPSCs Market Size by Region (2020-2025)

8.4 Asia-Pacific Human iPSCs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Human iPSCs Market Size (2020-2031)

9.2 Latin America Human iPSCs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Human iPSCs Market Size by Country (2020-2025)

9.4 Latin America Human iPSCs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Human iPSCs Market Size (2020-2031)

10.2 Middle East & Africa Human iPSCs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Human iPSCs Market Size by Country (2020-2025)

10.4 Middle East & Africa Human iPSCs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Fujifilm Holding Corporation (CDI)

11.1.1 Fujifilm Holding Corporation (CDI) Company Details

11.1.2 Fujifilm Holding Corporation (CDI) Business Overview

11.1.3 Fujifilm Holding Corporation (CDI) Human iPSCs Introduction

11.1.4 Fujifilm Holding Corporation (CDI) Revenue in Human iPSCs Business (2020-2025)

11.1.5 Fujifilm Holding Corporation (CDI) Recent Development

11.2 Ncardia

11.2.1 Ncardia Company Details

11.2.2 Ncardia Business Overview

11.2.3 Ncardia Human iPSCs Introduction

11.2.4 Ncardia Revenue in Human iPSCs Business (2020-2025)

11.2.5 Ncardia Recent Development

11.3 Sumitomo Dainippon Pharma

11.3.1 Sumitomo Dainippon Pharma Company Details

11.3.2 Sumitomo Dainippon Pharma Business Overview

11.3.3 Sumitomo Dainippon Pharma Human iPSCs Introduction

11.3.4 Sumitomo Dainippon Pharma Revenue in Human iPSCs Business (2020-2025)

11.3.5 Sumitomo Dainippon Pharma Recent Development

11.4 Astellas Pharma Inc

11.4.1 Astellas Pharma Inc Company Details

11.4.2 Astellas Pharma Inc Business Overview

11.4.3 Astellas Pharma Inc Human iPSCs Introduction

11.4.4 Astellas Pharma Inc Revenue in Human iPSCs Business (2020-2025)

11.4.5 Astellas Pharma Inc Recent Development

11.5 Fate Therapeutics, Inc

11.5.1 Fate Therapeutics, Inc Company Details

11.5.2 Fate Therapeutics, Inc Business Overview

11.5.3 Fate Therapeutics, Inc Human iPSCs Introduction

11.5.4 Fate Therapeutics, Inc Revenue in Human iPSCs Business (2020-2025)

11.5.5 Fate Therapeutics, Inc Recent Development

11.6 Pluricell Biotech

11.6.1 Pluricell Biotech Company Details

11.6.2 Pluricell Biotech Business Overview

11.6.3 Pluricell Biotech Human iPSCs Introduction

11.6.4 Pluricell Biotech Revenue in Human iPSCs Business (2020-2025)

11.6.5 Pluricell Biotech Recent Development

11.7 Cell Inspire Biotechnology

11.7.1 Cell Inspire Biotechnology Company Details

11.7.2 Cell Inspire Biotechnology Business Overview

11.7.3 Cell Inspire Biotechnology Human iPSCs Introduction

11.7.4 Cell Inspire Biotechnology Revenue in Human iPSCs Business (2020-2025)

11.7.5 Cell Inspire Biotechnology Recent Development

11.8 ReproCELL

11.8.1 ReproCELL Company Details

11.8.2 ReproCELL Business Overview

11.8.3 ReproCELL Human iPSCs Introduction

11.8.4 ReproCELL Revenue in Human iPSCs Business (2020-2025)

11.8.5 ReproCELL Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Fujifilm Holding Corporation (CDI)

Ncardia

Sumitomo Dainippon Pharma

Astellas Pharma Inc

Fate Therapeutics, Inc

Pluricell Biotech

Cell Inspire Biotechnology

Reprocell

List of Tables

Table 1. Global Human iPSCs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Skin

Table 3. Key Players of Blood Cells

Table 4. Global Human iPSCs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Human iPSCs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Human iPSCs Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Human iPSCs Market Share by Region (2020-2025)

Table 8. Global Human iPSCs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Human iPSCs Market Share by Region (2026-2031)

Table 10. Human iPSCs Market Trends

Table 11. Human iPSCs Market Drivers

Table 12. Human iPSCs Market Challenges

Table 13. Human iPSCs Market Restraints

Table 14. Global Human iPSCs Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Human iPSCs Market Share by Players (2020-2025)

Table 16. Global Top Human iPSCs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human iPSCs as of 2024)

Table 17. Ranking of Global Top Human iPSCs Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Human iPSCs Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Human iPSCs, Headquarters and Area Served

Table 20. Global Key Players of Human iPSCs, Product and Application

Table 21. Global Key Players of Human iPSCs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Human iPSCs Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Human iPSCs Revenue Market Share by Type (2020-2025)

Table 25. Global Human iPSCs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Human iPSCs Revenue Market Share by Type (2026-2031)

Table 27. Global Human iPSCs Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Human iPSCs Revenue Market Share by Application (2020-2025)

Table 29. Global Human iPSCs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Human iPSCs Revenue Market Share by Application (2026-2031)

Table 31. North America Human iPSCs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Human iPSCs Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Human iPSCs Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Human iPSCs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Human iPSCs Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Human iPSCs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Human iPSCs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Human iPSCs Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Human iPSCs Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Human iPSCs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Human iPSCs Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Human iPSCs Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Human iPSCs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Human iPSCs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Human iPSCs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Fujifilm Holding Corporation (CDI) Company Details

Table 47. Fujifilm Holding Corporation (CDI) Business Overview

Table 48. Fujifilm Holding Corporation (CDI) Human iPSCs Product

Table 49. Fujifilm Holding Corporation (CDI) Revenue in Human iPSCs Business (2020-2025) & (US$ Million)

Table 50. Fujifilm Holding Corporation (CDI) Recent Development

Table 51. Ncardia Company Details

Table 52. Ncardia Business Overview

Table 53. Ncardia Human iPSCs Product

Table 54. Ncardia Revenue in Human iPSCs Business (2020-2025) & (US$ Million)

Table 55. Ncardia Recent Development

Table 56. Sumitomo Dainippon Pharma Company Details

Table 57. Sumitomo Dainippon Pharma Business Overview

Table 58. Sumitomo Dainippon Pharma Human iPSCs Product

Table 59. Sumitomo Dainippon Pharma Revenue in Human iPSCs Business (2020-2025) & (US$ Million)

Table 60. Sumitomo Dainippon Pharma Recent Development

Table 61. Astellas Pharma Inc Company Details

Table 62. Astellas Pharma Inc Business Overview

Table 63. Astellas Pharma Inc Human iPSCs Product

Table 64. Astellas Pharma Inc Revenue in Human iPSCs Business (2020-2025) & (US$ Million)

Table 65. Astellas Pharma Inc Recent Development

Table 66. Fate Therapeutics, Inc Company Details

Table 67. Fate Therapeutics, Inc Business Overview

Table 68. Fate Therapeutics, Inc Human iPSCs Product

Table 69. Fate Therapeutics, Inc Revenue in Human iPSCs Business (2020-2025) & (US$ Million)

Table 70. Fate Therapeutics, Inc Recent Development

Table 71. Pluricell Biotech Company Details

Table 72. Pluricell Biotech Business Overview

Table 73. Pluricell Biotech Human iPSCs Product

Table 74. Pluricell Biotech Revenue in Human iPSCs Business (2020-2025) & (US$ Million)

Table 75. Pluricell Biotech Recent Development

Table 76. Cell Inspire Biotechnology Company Details

Table 77. Cell Inspire Biotechnology Business Overview

Table 78. Cell Inspire Biotechnology Human iPSCs Product

Table 79. Cell Inspire Biotechnology Revenue in Human iPSCs Business (2020-2025) & (US$ Million)

Table 80. Cell Inspire Biotechnology Recent Development

Table 81. ReproCELL Company Details

Table 82. ReproCELL Business Overview

Table 83. ReproCELL Human iPSCs Product

Table 84. ReproCELL Revenue in Human iPSCs Business (2020-2025) & (US$ Million)

Table 85. ReproCELL Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Human iPSCs Picture

Figure 2. Global Human iPSCs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human iPSCs Market Share by Type: 2024 VS 2031

Figure 4. Skin Features

Figure 5. Blood Cells Features

Figure 6. Global Human iPSCs Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Human iPSCs Market Share by Application: 2024 VS 2031

Figure 8. Academic Research Case Studies

Figure 9. Drug Development and Discovery Case Studies

Figure 10. Toxicity Screening Case Studies

Figure 11. Regenerative Medicine Case Studies

Figure 12. Others Case Studies

Figure 13. Human iPSCs Report Years Considered

Figure 14. Global Human iPSCs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Human iPSCs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Human iPSCs Market Share by Region: 2024 VS 2031

Figure 17. Global Human iPSCs Market Share by Players in 2024

Figure 18. Global Top Human iPSCs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human iPSCs as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Human iPSCs Revenue in 2024

Figure 20. North America Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Human iPSCs Market Share by Country (2020-2031)

Figure 22. United States Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Human iPSCs Market Share by Country (2020-2031)

Figure 26. Germany Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Human iPSCs Market Share by Region (2020-2031)

Figure 34. China Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Human iPSCs Market Share by Country (2020-2031)

Figure 42. Mexico Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Human iPSCs Market Share by Country (2020-2031)

Figure 46. Turkey Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Human iPSCs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Fujifilm Holding Corporation (CDI) Revenue Growth Rate in Human iPSCs Business (2020-2025)

Figure 50. Ncardia Revenue Growth Rate in Human iPSCs Business (2020-2025)

Figure 51. Sumitomo Dainippon Pharma Revenue Growth Rate in Human iPSCs Business (2020-2025)

Figure 52. Astellas Pharma Inc Revenue Growth Rate in Human iPSCs Business (2020-2025)

Figure 53. Fate Therapeutics, Inc Revenue Growth Rate in Human iPSCs Business (2020-2025)

Figure 54. Pluricell Biotech Revenue Growth Rate in Human iPSCs Business (2020-2025)

Figure 55. Cell Inspire Biotechnology Revenue Growth Rate in Human iPSCs Business (2020-2025)

Figure 56. ReproCELL Revenue Growth Rate in Human iPSCs Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions